Page 99 - GPD-3-2

Gene & Protein in Disease A review of exosome-mediated treatments

65. Ha DH, Kim SD, Lee J, et al. Toxicological evaluation of doi: 10.1111/jcmm.16290
exosomes derived from human adipose tissue-derived 77. Klyushnenkova E, Mosca JD, Zernetkina V, et al. T cell
mesenchymal stem/stromal cells. Regul Toxicol Pharmacol. responses to allogeneic human mesenchymal stem cells:
2020;115:104686.
Immunogenicity, tolerance, and suppression. J Biomed Sci.
doi: 10.1016/j.yrtph.2020.104686 2005;12(1):47-57.
66. U.S. Food and Drug Administration. Public safety alert doi: 10.1007/s11373-004-8183-7
due to marketing of unapproved stem cell and exosome
products. In: Public Saftey Notice. United States: U.S. Food 78. Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J. Clinical
and Drug Administration; 2019. p. 1. applications of stem cell-derived exosomes. Signal Transduct
Target Ther. 2024;9(1):17.
67. Rezaie J, Feghhi M, Etemadi T. A review on exosomes
application in clinical trials: Perspective, questions, and doi: 10.1038/s41392-023-01704-0
challenges. Cell Commun Signal. 2022;20(1):145. 79. Raimondo S, Giavaresi G, Lorico A, Alessandro R.
doi: 10.1186/s12964-022-00959-4 Extracellular vesicles as biological shuttles for targeted
therapies. Int J Mol Sci. 2019;20(8):1848.
68. Yasuda S, Kusakawa S, Kuroda T, et al. Tumorigenicity-
associated characteristics of human iPS cell lines. PLoS One. doi: 10.3390/ijms20081848
2018;13(10):e0205022. 80. Akuma P, Okagu OD, Udenigwe CC. Naturally occurring
doi: 10.1371/journal.pone.0205022 exosome vesicles as potential delivery vehicle for bioactive
compounds. Front Sustain Food Syst. 2019;3:23.
69. Hentze H, Soong PL, Wang ST, Phillips BW, Putti TC,
Dunn NR. Teratoma formation by human embryonic stem doi: 10.3389/fsufs.2019.00023
cells: Evaluation of essential parameters for future safety 81. Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: Biogenesis,
studies. Stem Cell Res. 2009;2(3):198-210. biologic function and clinical potential. Cell Biosci.
doi: 10.1016/j.scr.2009.02.002 2019;9:19.
70. Sato Y, Bando H, Di Piazza M, et al. Tumorigenicity doi: 10.1186/s13578-019-0282-2
assessment of cell therapy products: The need for 82. Syromiatnikova V, Prokopeva A, Gomzikova M. Methods of
global consensus and points to consider. Cytotherapy. the large-scale production of extracellular vesicles. Int J Mol
2019;21(11):1095-1111. Sci. 2022;23(18):10522.
doi: 10.1016/j.jcyt.2019.10.001 doi: 10.3390/ijms231810522
71. Zhang K, Cheng K. Stem cell-derived exosome versus stem 83. Ahn SH, Ryu SW, Choi H, You S, Park J, Choi C.
cell therapy. Nat Rev Bioeng. 2023;1:1-2. Manufacturing therapeutic exosomes: From bench to
doi: 10.1038/s44222-023-00064-2 industry. Mol Cells. 2022;45(5):284-290.
72. Xu JY, Chen GH, Yang YJ. Exosomes: A rising star in falling doi: 10.14348/molcells.2022.2033
hearts. Front Physiol. 2017;8:494. 84. Görgens A, Corso G, Hagey DW, et al. Identification
doi: 10.3389/fphys.2017.00494 of storage conditions stabilizing extracellular vesicles
preparations. J Extracell Vesicles. 2022;11(6):e12238.
73. Taghiabadi E, Nilforoushzadeh MA, Aghdami N.
Maintaining hair inductivity in human dermal Papilla cells: doi: 10.1002/jev2.12238
A review of effective methods. Skin Pharmacol Physiol. 85. Mu N, Li J, Zeng L, et al. Plant-derived exosome-like
2020;33(5):280-292. nanovesicles: Current progress and prospects. Int J
doi: 10.1159/000510152 Nanomedicine. 2023;18:4987-5009.
74. Mendt M, Rezvani K, Shpall E. Mesenchymal stem cell- doi: 10.2147/ijn.S420748
derived exosomes for clinical use. Bone Marrow Transplant. 86. Zeringer E, Barta T, Li M, Vlassov AV. Strategies
2019;54(Suppl 2):789-792. for isolation of exosomes. Cold Spring Harb Protoc.
doi: 10.1038/s41409-019-0616-z 2015;2015(4):319-323.
75. Hanyu-Deutmeyer A, Buchheit T. Exosomes: The good, the doi: 10.1101/pdb.top074476
bad, and the ugly. ASRA Pain Med News. 2023;48. 87. Yi Q, Xu Z, Thakur A, et al. Current understanding of
doi: 10.52211/asra050123.009 plant-derived exosome-like nanoparticles in regulating
the inflammatory response and immune system
76. Song H, Zhao J, Cheng J, et al. Extracellular vesicles in
chondrogenesis and cartilage regeneration. J Cell Mol Med. microenvironment. Pharmacol Res. 2023;190:106733.
2021;25(11):4883-4892. doi: 10.1016/j.phrs.2023.106733

Volume 3 Issue 2 (2024) 15 doi: 10.36922/gpd.3230